First Time Loading...

Inotiv Inc
NASDAQ:NOTV

Watchlist Manager
Inotiv Inc Logo
Inotiv Inc
NASDAQ:NOTV
Watchlist
Price: 4.32 USD -8.09% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

NOTV's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. [ Read More ]

The intrinsic value of one NOTV stock under the Base Case scenario is 39.16 USD. Compared to the current market price of 4.32 USD, Inotiv Inc is Undervalued by 89%.

Key Points:
NOTV Intrinsic Value
Base Case
39.16 USD
Undervaluation 89%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Inotiv Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NOTV stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Inotiv Inc

Provide an overview of the primary business activities
of Inotiv Inc.

What unique competitive advantages
does Inotiv Inc hold over its rivals?

What risks and challenges
does Inotiv Inc face in the near future?

Has there been any significant insider trading activity
in Inotiv Inc recently?

Summarize the latest earnings call
of Inotiv Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inotiv Inc.

Provide P/S
for Inotiv Inc.

Provide P/E
for Inotiv Inc.

Provide P/OCF
for Inotiv Inc.

Provide P/FCFE
for Inotiv Inc.

Provide P/B
for Inotiv Inc.

Provide EV/S
for Inotiv Inc.

Provide EV/GP
for Inotiv Inc.

Provide EV/EBITDA
for Inotiv Inc.

Provide EV/EBIT
for Inotiv Inc.

Provide EV/OCF
for Inotiv Inc.

Provide EV/FCFF
for Inotiv Inc.

Provide EV/IC
for Inotiv Inc.

Show me price targets
for Inotiv Inc made by professional analysts.

What are the Revenue projections
for Inotiv Inc?

How accurate were the past Revenue estimates
for Inotiv Inc?

What are the Net Income projections
for Inotiv Inc?

How accurate were the past Net Income estimates
for Inotiv Inc?

What are the EPS projections
for Inotiv Inc?

How accurate were the past EPS estimates
for Inotiv Inc?

What are the EBIT projections
for Inotiv Inc?

How accurate were the past EBIT estimates
for Inotiv Inc?

Compare the revenue forecasts
for Inotiv Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inotiv Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inotiv Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inotiv Inc compared to its peers.

Compare the P/E ratios
of Inotiv Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Inotiv Inc with its peers.

Analyze the financial leverage
of Inotiv Inc compared to its main competitors.

Show all profitability ratios
for Inotiv Inc.

Provide ROE
for Inotiv Inc.

Provide ROA
for Inotiv Inc.

Provide ROIC
for Inotiv Inc.

Provide ROCE
for Inotiv Inc.

Provide Gross Margin
for Inotiv Inc.

Provide Operating Margin
for Inotiv Inc.

Provide Net Margin
for Inotiv Inc.

Provide FCF Margin
for Inotiv Inc.

Show all solvency ratios
for Inotiv Inc.

Provide D/E Ratio
for Inotiv Inc.

Provide D/A Ratio
for Inotiv Inc.

Provide Interest Coverage Ratio
for Inotiv Inc.

Provide Altman Z-Score Ratio
for Inotiv Inc.

Provide Quick Ratio
for Inotiv Inc.

Provide Current Ratio
for Inotiv Inc.

Provide Cash Ratio
for Inotiv Inc.

What is the historical Revenue growth
over the last 5 years for Inotiv Inc?

What is the historical Net Income growth
over the last 5 years for Inotiv Inc?

What is the current Free Cash Flow
of Inotiv Inc?

Financials

Balance Sheet Decomposition
Inotiv Inc

Current Assets 190.7m
Cash & Short-Term Investments 22m
Receivables 92.2m
Other Current Assets 76.5m
Non-Current Assets 644.8m
PP&E 239.5m
Intangibles 394.6m
Other Non-Current Assets 10.6m
Current Liabilities 109.5m
Accounts Payable 30.7m
Accrued Liabilities 22.7m
Other Current Liabilities 56.1m
Non-Current Liabilities 471.9m
Long-Term Debt 370.9m
Other Non-Current Liabilities 100.9m
Efficiency

Earnings Waterfall
Inotiv Inc

Revenue
585.2m USD
Cost of Revenue
-408.1m USD
Gross Profit
177.2m USD
Operating Expenses
-170.9m USD
Operating Income
6.3m USD
Other Expenses
-39.5m USD
Net Income
-33.3m USD

Free Cash Flow Analysis
Inotiv Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

NOTV Profitability Score
Profitability Due Diligence

Inotiv Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
Positive Gross Profit
ROIC is Increasing
40/100
Profitability
Score

Inotiv Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

NOTV Solvency Score
Solvency Due Diligence

Inotiv Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
24/100
Solvency
Score

Inotiv Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NOTV Price Targets Summary
Inotiv Inc

Wall Street analysts forecast NOTV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOTV is 15.81 USD with a low forecast of 10.1 USD and a high forecast of 26.25 USD.

Lowest
Price Target
10.1 USD
134% Upside
Average
Price Target
15.81 USD
266% Upside
Highest
Price Target
26.25 USD
508% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NOTV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NOTV Price
Inotiv Inc

1M 1M
-55%
6M 6M
+88%
1Y 1Y
-21%
3Y 3Y
-79%
5Y 5Y
+125%
10Y 10Y
+57%
Annual Price Range
4.32
52w Low
1.68
52w High
11.04
Price Metrics
Average Annual Return 113.13%
Standard Deviation of Annual Returns 141.84%
Max Drawdown -97%
Shares Statistics
Market Capitalization 111.4m USD
Shares Outstanding 25 790 700
Percentage of Shares Shorted 3.83%

NOTV Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Inotiv Inc Logo
Inotiv Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

111.4m USD

Dividend Yield

0%

Description

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company is headquartered in West Lafayette, Indiana and currently employs 541 full-time employees. The firm focuses on providing drug developers with scientific research and analytical instrumentation. The firm operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.

Contact

INDIANA
West Lafayette
2701 Kent Ave
+13174634527.0
https://www.inotivco.com/

IPO

1997-11-25

Employees

541

Officers

President, CEO & Director
Mr. Robert W. Leasure Jr.
Senior VP of Finance & CFO
Ms. Beth A. Taylor CPA
Chief Strategy Officer & Director
Dr. John E. Sagartz D.V.M., DiplomateACVP, Ph.D.
Founder, Chairman Emeritus & Scientific Advisor
Dr. Peter T. Kissinger
VP of Finance, Principal Accounting Officer & Corporate Controller
Mr. Brennan Freeman
Senior VP, General Counsel & Corporate Secretary
Ms. Andrea Castetter
Show More
Executive VP of Global Marketing & Corporate Development
Dr. Adrian Hardy Ph.D.
Chief Human Resources Officer
Mr. Jeffrey Arthur Krupp
Chief Operating Officer of DSA
Mr. John Gregory Beattie DSA
Chief Commercial Officer
Mr. Michael Garrett M.S.
Show Less

See Also

Discover More
What is the Intrinsic Value of one NOTV stock?

The intrinsic value of one NOTV stock under the Base Case scenario is 39.16 USD.

Is NOTV stock undervalued or overvalued?

Compared to the current market price of 4.32 USD, Inotiv Inc is Undervalued by 89%.